Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: J Hepatol. 2014 Mar 5;61(1):139–147. doi: 10.1016/j.jhep.2014.02.021

Fig. 2. The combination of Slco1b2−/− and diet-induced NASH dramatically increases pravastatin exposure.

Fig. 2

(A) Pravastatin plasma concentrations. (B) Plasma area under the curve (AUC) (0-40 min). (C) Pravastatin concentrations in gastrocnemius and soleus muscles. (D) Liver pravastatin concentrations and liver to plasma ratios. (E) Kidney pravastatin concentrations and kidney to plasma ratios. Data represent mean ± SEM. WT control n=6, WT NASH n=4, Slco1b2 KO control n=4, Slco1b2 KO NASH n=4. Two-way ANOVA p-values are shown in the table. *p-value <0.05 according to a Two-way ANOVA Bonferroni multiple comparison post-test.